Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grant
Rhea-AI Filing Summary
Gaggar Anuj reported acquisition or exercise transactions in this Form 4 filing.
Assembly Biosciences Chief Medical Officer Anuj Gaggar reported an equity compensation grant in the form of 14,000 shares of common stock at a price of $0.00 per share. These shares reflect restricted stock units that became issuable after stockholders approved an amendment to the company’s 2018 Stock Incentive Plan on June 4, 2026.
The RSUs vest in four approximately equal installments on March 29, 2027, March 29, 2028, March 29, 2029, and March 29, 2030, assuming continuous service. Following this award and prior ESPP purchases, Gaggar now holds 42,688 common shares directly, indicating a routine compensation-related increase in ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 14,000 shares
Net Buy
1 txn
Insider
Gaggar Anuj
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 42,688 shares (Direct)
Footnotes (2)
- F1. Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increased the number of shares of common stock authorized for issuance under the Plan (the "Plan Amendment"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030.
- F2. Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026.
Key Figures
Equity grant size: 14,000 shares
Post-transaction holdings: 42,688 shares
ESPP shares included: 688 shares
+3 more
6 metrics
Equity grant size
14,000 shares
Common stock granted as RSUs at $0.00 per share
Post-transaction holdings
42,688 shares
Total common shares directly held after the grant
ESPP shares included
688 shares
Acquired under 2018 Employee Stock Purchase Plan on May 14, 2026
Equity grant proportion
35% of annual equity grant
RSUs represent 35% of Gaggar’s annual equity grant
Vesting dates
2027, 2028, 2029, 2030
Four approximately equal annual installments starting March 29, 2027
Plan amendment approval date
June 4, 2026
Stockholders approved amendment increasing authorized shares under 2018 Plan
Key Terms
Restricted stock units ("RSUs"), Amended and Restated 2018 Stock Incentive Plan, Plan Amendment, Employee Stock Purchase Plan, +1 more
5 terms
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Amended and Restated 2018 Stock Incentive Plan financial
"an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan..."
Plan Amendment regulatory
"authorized for issuance under the Plan (the "Plan Amendment"). Although the RSUs were granted..."
Employee Stock Purchase Plan financial
"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan..."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
continuous service other
"vest in four approximately equal installments, assuming continuous service on each vesting date..."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did ASMB Chief Medical Officer Anuj Gaggar report?
Anuj Gaggar reported receiving 14,000 shares of Assembly Biosciences common stock as an equity grant. The award was made at $0.00 per share and represents restricted stock units tied to the company’s 2018 Stock Incentive Plan.
How are Anuj Gaggar’s new Assembly Biosciences RSUs scheduled to vest?
The RSUs vest in four approximately equal installments over four years. Vesting dates are March 29, 2027, March 29, 2028, March 29, 2029, and March 29, 2030, and each installment requires Gaggar to remain in continuous service.
What approval was required for Anuj Gaggar’s ASMB RSU grant?
The RSU grant was contingent on stockholder approval of an amendment to Assembly Biosciences’ 2018 Stock Incentive Plan. Stockholders approved this Plan Amendment on June 4, 2026, increasing authorized shares and making the RSUs issuable under the plan.